AFP and fungal infectious disease: Not reported overall, available for 73/74 patients with proven/probable IA (80% AFP (43% PSZ, 24% FCZ, ITZ 17%, L-AMB 12%), 20% no AFP);5.1% probable/proven IA (0.7% (10/1450) proven (10/10 b-IFDs), 4.4% (64/1450) probable (48/64 b-IFDs)), 21% (14/74) of patients with proven/probable IA had a previous fungal infection;Not available;Proven IA (ten): four A. fumigates, three A. niger, two A. terreus, one A. oryzae (3/10 b-IFDs during PSZ-AFP);Overall, serum and BAL GM positive in 54/74 (73%) and 17/74 (23%), respectively.